In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.
In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.
复制标题
马波沙星在犊牛组织笼模型中对多杀性巴氏杆菌的体内抗菌活性
DOI:
10.3389/fmicb.2015.00759
复制
发表时间:
2015
影响因子:
5.2
通讯作者:
Zeng Z
中科院分区:
文献类型:
--
作者:
Cao C;Qu Y;Sun M;Qiu Z;Huang X;Huai B;Lu Y;Zeng Z
Marbofloxacin is a fluoroquinolone specially developed for use in veterinary medicine with broad-spectrum antibacterial activity. The objective of our study was to re-evaluate in vivo antimicrobial activity of marbofloxacin against Pasteurella multocida using subcutaneously implanted tissue cages in calves. Calves were infected by direct injection into tissue cages with P. multocida(type B, serotype 2), then intramuscularly received a range of marbofloxacin doses 24 h after inoculation. The ratio of 24 h area under the concentration-time curve divided by the minimum inhibitory concentration or the mutant prevention concentration (AUC24 h/MIC or AUC24 h/MPC) was the pharmacokinetic-pharmacodynamic (PK/PD) index that best described the effectiveness of marbofloxacin against P. multocida (R2 = 0.8514) by non-linear regression analysis. Marbofloxacin exhibited a good antimicrobial activity in vivo. The levels of AUC24 h/MIC and AUC24 h/MPC that produced 50% (1.5log10 CFU/mL reduction) and 90% (3log10 CFU/mL reduction) of maximum response were 18.60 and 50.65 h, 4.67 and 12.89 h by using sigmoid Emax model WINNONLIN software, respectively. The in vivo PK/PD integrated methods by tissue cage model display the advantage of the evaluation of antimicrobial activity and the optimization of the dosage regimen for antibiotics in the presence of the host defenses, especially in target animal of veterinary interest.